Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia - GBI Research Reports

Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia

Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia - GBI Research Reports
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Published Sep 01, 2011
97 pages — Published Sep 01, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider, has released its latest research, Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia. It gives a robust idea about the patient recruitment status by geography, by sponsor company, and by year for all the major CNS indications. Furthermore, the report provides profiles of prevalence with forecast data up to 2017 for all the major CNS indications. The major indications covered in the report are Alzheimers disease, Parkinsons disease, Epilepsy, Schizophrenia and Depression. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

GBI Research found that the highest number of trials was conducted in schizophrenia, which corresponds to the highest levels of patient recruitment for the period 2000-2009, for trials which were industry sponsored with completed status. Within the CNS market, the Alzheimers and Parkinsons disease sectors have been identified as the fastest growing sectors. In terms of reimbursement, countries like Germany, France and Canada have been identified as having the most robust and patient-friendly regulations for CNS therapeutics. The central nervous system is a complex and sophisticated system that regulates and co-ordinates the basic functions and activities of the human body. The human central nervous system consists of the brain, spinal cord and the neural network connecting these to the body. Owing to its complexity and intricacies, the CNS is vulnerable to various complications and disorders. Disorders within the CNS are primarily associated with the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system and the neuromuscular network, including the muscles. A substantial portion of CNS disorders can be grouped under neurodegenerative disorders such as Alzheimers, which are primarily associated with the deterioration or break down of cerebral and spinal cells. Other diseases associated with the CNS include psychiatric or mental disorders such as Attention Deficit Hyperactivity Disorder (ADHD). These disorders are related to individuals psychological or behavioral patterns, and are thought to cause distress or disabilities that are not expected as part of normal development. Other major neurological disorders include epilepsy, pain and sleep related complications such as migraine and insomnia.

Scope

The report analyzes the clinical trial recruitment trends of the pharmaceutical companies for various neurology trials. Its scope includes -
- Insight on Clinical Trials conducted for major indications of neurology such as Alzheimers disease, Parkinsons disease, Epilepsy, Schizophrenia and Depression from 2000-2009.
- The status of patient recruitment by geography, Sponsor Company, year and stage of development.
- Analysis of the average number of patients recruited per trial for major indications per year.
- Analysis of the average number of patients recruited per trial for major indications by stage of development.
- The prevalence population in India, China and Brazil for all major indications from 2010-2017.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Identify and understand the status of clinical trials conducted for major neurology indications from 2000-2009.
- Build understanding of patient recruitment status by geography, Sponsor Company, year and stage of development.
- Identify the prevalence population for the major indications up to 2017.
- Identify the average number of patients recruited by stage of development and across yea

  
Source:
Document ID
GBIHC119MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents39
  List of Tables63
  List of Figures93
Clinical Trial Recruitment in Central Nervous System Disorders - Introduction122
  GBI Research Report Guidance131
Clinical Trials Overview1410
  Clinical Trials Share by Therapeutic Area147
  Clinical Trials by Pharmaceutical Companies, 2005-2010211
  Clinical Trials and Patient Recruitment in CNS222
Clinical Trials and Patient Recruitment for Alzheimer s Disease2414
  Introduction241
  Clinical Trials for Alzheimer s Disease251
    Number of Clinical Trials by Stage of Development251
    Number of Clinical Trials by Sponsor261
    Number of Clinical Trials by Geography271
    Number of Clinical Trials by Year281
  Prevalence Population for Alzheimer s disease (2010-2017)291
    Brazil291
    India301
    China311
  Patient Recruitment for Alzheimer s Disease321
    Number of Patients Recruited by Stage of Development321
    Number of Patients Recruited by Sponsor331
    Number of Patients Recruited by Geography341
    Number of Patients Recruited Per Year351
  Average Number of Patients Recruited Per Trial361
    Average Number of Patients Recruited Per Trial by Stage of Development361
    Average Number of Patients Recruited Per Trial Per Year371
Clinical Trials and Patient Recruitment for Parkinson s Disease3814
  Introduction381
  Clinical Trials for Parkinson s Disease391
    Number of Clinical Trials by Stage of Development391
    Number of Clinical Trials by Sponsor401
    Number of Clinical Trials by Geography411
    Number of Clinical Trials by Year421
  Prevalence Population for Parkinson s disease (2010-2017)431
    Brazil431
    India441
    China451
  Patient Recruitment for Parkinson s Disease461
    Number of Patients Recruited by Stage of Development461
    Number of Patients Recruited by Sponsor471
    Number of Patients Recruited by Geography481
    Number of Patients Recruited Per Year491
  Average Number of Patients Recruited Per Trial501
    Average Number of Patients Recruited Per Trial by Stage of Development501
    Average Number of Patients Reruited per Trial per Year511
Clinical Trials and Patient Recruitment for Epilepsy5214
  Introduction521
  Clinical Trials for Epilepsy531
    Number of Clinical Trials by Stage of Development531
    Number of Clinical Trials by Sponsor541
    Number of Clinical Trials by Geography551
    Number of Clinical Trials by Year561
  Prevalence Population for Epilepsy (2010-2017)571
    Brazil571
    India581
    China591
  Patient Recruitment for Epilepsy601
    Number of Patients Recruited by Stage of Development601
    Number of Patients Recruited by Sponsor611
    Number of Patients Recruited by Geography621
    Number of Patients Recruited Per Year631
  Average Number of Patients Recruited Per Trial641
    Average Number of Patients Recruited Per Trial by Stage of Development641
    Average Number of Patients Recruited Per Trial Per Year651
Clinical Trials and Patient Recruitment for Schizophrenia6614
  Introduction661
  Clinical Trials for Schizophrenia671
    Number of Clinical Trials by Stage of Development671
    Number of Clinical Trials by Sponsor681
    Number of Clinical Trials by Geography691
    Number of Clinical Trials by Year701
  Prevalence Population for Schizophrenia (2010-2017)711
    Brazil711
    India721
    China731
  Patient Recruitment for Schizophrenia741
    Number of Patients Recruited by Stage of Development741
    Number of Patients Recruited by Sponsor751
    Number of Patients Recruited by Geography761
    Number of Patients Recruited Per Year771
  Average Number of Patients Recruited Per Trial781
    Average Number of Patients Recruited Per Trial by Stage of Development781
    Average Number of Patients Recruited Per Trial Per Year791
Clinical Trials and Patient Recruitment for Depression8014
  Introduction801
  Clinical Trials for Depression811
    Number of Clinical Trials by Stage of Development811
    Number of Clinical Trials by Sponsor821
    Number of Clinical Trials by Geography831
    Number of Clinical Trials by Year841
  Prevalence Population for Depression (2010-2017)851
    Brazil851
    India861
    China871
  Patient Recruitment for Depression881
    Number of Patients Recruited by Stage of Development881
    Number of Patients Recruited by Sponsor891
    Number of Patients Recruited by Geography901
    Number of Patients Recruited Per Year911
  Average Number of Patients Recruited Per Trial921
    Average Number of Patients Recruited per Trial by Stage of Development921
    Average Number of Patients Recruited per Trial per Year931
Clinical Trials Recruitment in Central Nervous System: Appendix944
  Market Definitions941
  Abbreviations941
  Research Methodology943
    Coverage941
    Secondary Research951
    Primary Research951
    Expert Panel Validation951
    Section-wise methodology951
      Clinical Trials Overview961
      Number of Clinical Trials961
      Patient Recruitment Status961
      Prevalence of Disease in India, China and Brazil (2010-2017)961
  Contact Us971
  Disclaimer971
  Sources971

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia" Sep 01, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Clinical-Trial-Recruitment-in-Central-Nervous-System-Disorders-Highest-Number-of-Patients-were-Recruited-for-Clinical-Trials-in-Schizophrenia-2115-249>
  
APA:
GBI Research Reports. (2011). Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia Sep 01, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Clinical-Trial-Recruitment-in-Central-Nervous-System-Disorders-Highest-Number-of-Patients-were-Recruited-for-Clinical-Trials-in-Schizophrenia-2115-249>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.